Department of Surgery, VU University Medical Center, Amsterdam, The Netherlands.
Surg Endosc. 2010 Sep;24(9):2182-7. doi: 10.1007/s00464-010-0923-3. Epub 2010 Feb 23.
The sentinel lymph node (SLN) procedure alter the strategy for the treatment of patients with colon cancer. New techniques emerge that may provide the surgeon with a tool for accurate intraoperative detection of the SLNs.
An SLN procedure of the sigmoid was used in six goats. During laparoscopy, the near-infrared dye indocyanine green (ICG) was injected into the subserosa of the sigmoid via a percutaneously inserted needle during four experiments and in the submucosa during colonoscopy in two experiments. After injection, the near-infrared features of a newly developed laparoscope were used to detect the lymph vessels and SLNs. At the end of the procedure, 2 h after injection, all the goats were killed, and autopsy was performed. During postmortem laparotomy, the sigmoid was removed and used for confirmation of ICG node uptake.
In all the procedures, the lymph vessels were easily detected by their bright fluorescent emission. In the first two experiments, no lymph nodes were detected. In the subsequent four experiments, human serum albumin was added to the ICG solution before injection to enable better lymph node entrapment. In all four experiments, at least one bright fluorescent lymph node was found after the lymph vessels had been tracked by their fluorescent guidance. The mean time between injection and SLN identification was 10 min. In two cases, the SLNs were located up to 5 mm into the fat tissue of the mesentery and were not seen by regular vision of the laparoscope. By switching on the near-infrared features of the scope, a clear bright dot became visible, which increased in intensity after opening of the mesentery.
The SLN procedure for the sigmoid using near-infrared laparoscopy in the goat is a very promising technique. Achievements described in this report justify a clinical trial on the feasibility of ICG-guided SLN detection in humans.
前哨淋巴结(SLN)检测改变了结肠癌患者的治疗策略。新的技术不断涌现,这可能为外科医生提供一种在术中准确检测 SLN 的工具。
本研究对 6 只山羊的乙状结肠进行了 SLN 检测。在腹腔镜检查过程中,通过经皮插入的针将近红外染料吲哚菁绿(ICG)注入乙状结肠的浆膜下,在 4 次实验中,在结肠镜检查中注入黏膜下。注射后,使用新开发的腹腔镜的近红外特征来检测淋巴管和 SLN。在手术结束时,在注射后 2 小时处死所有山羊,并进行尸检。在剖腹手术后,切除乙状结肠并用于确认 ICG 摄取。
在所有手术中,通过明亮的荧光发射很容易检测到淋巴管。在前两次实验中,没有检测到淋巴结。在随后的 4 次实验中,在注射前将人血清白蛋白加入 ICG 溶液中,以更好地捕获淋巴结。在所有 4 次实验中,在跟踪淋巴管后,至少发现了一个明亮的荧光淋巴结。从注射到识别 SLN 的平均时间为 10 分钟。在 2 例中,SLN 位于肠系膜脂肪组织中 5mm 深处,通过常规腹腔镜检查无法看到。通过开启腹腔镜的近红外功能,一个清晰的明亮光点变得可见,打开肠系膜后强度增加。
在山羊中使用近红外腹腔镜进行乙状结肠 SLN 检测是一种很有前途的技术。本报告中描述的结果证明了在人类中进行 ICG 引导的 SLN 检测可行性的临床试验是合理的。